Elsoft Research Berhad (KLSE:ELSOFT)

Inozyme Pharma Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.11	4.2	9.46	11.2	12.84	3.41
Short-Term Investments	73.27	0.18	0.18	0.18	0.18	0.18
Trading Asset Securities	-	72.59	88.39	61.88	56.09	61.53
Cash & Short-Term Investments	77.38	76.96	98.03	73.26	69.11	65.13
Cash Growth	-19.94%	-21.49%	33.81%	6.01%	6.11%	-4.43%
Accounts Receivable	3.63	4.22	1.85	10.46	13.99	7.26
Other Receivables	0.93	0.52	0.18	34.26	0.08	0.04
Receivables	4.56	4.74	2.03	44.72	14.07	7.3
Inventory	2.63	2.66	3.14	3.64	4.78	2.78
Prepaid Expenses	-	0.19	0.14	0.1	0.17	-
Total Current Assets	84.57	84.55	103.34	121.73	88.13	75.21
Property, Plant & Equipment	17.9	18.03	18.68	19.23	19.81	20.44
Long-Term Investments	10.07	10	10.65	10.32	9.45	9.46
Goodwill	-	-	5.93	-	-	-
Other Intangible Assets	-	-	1.69	-	-	-
Other Long-Term Assets	1.26	1.26	0.11	0.11	2.6	2.68
Total Assets	113.79	113.83	140.39	151.39	119.98	107.79
Accounts Payable	0.26	0.3	0.25	0.61	1.72	0.52
Accrued Expenses	-	1.98	2.41	4.59	3.55	2.76
Current Income Taxes Payable	-	-	-	2.58	-	-
Current Unearned Revenue	0.19	0.62	0.98	2.47	4.1	1.19
Other Current Liabilities	3.22	0.86	0.91	1.26	1	0.72
Total Current Liabilities	3.67	3.77	4.56	11.51	10.36	5.2
Long-Term Deferred Tax Liabilities	1.05	1.05	1.42	0.95	0.96	0.9
Total Liabilities	4.72	4.82	5.98	12.46	11.31	6.09
Common Stock	57.83	57.83	57.83	48.81	47.41	44.69
Retained Earnings	59.41	59.34	77.58	91.02	61.48	57.25
Treasury Stock	-8.53	-8.53	-1.42	-1.37	-1.09	-1.09
Comprehensive Income & Other	0.37	0.37	0.41	0.47	0.87	0.84
Shareholders' Equity	109.07	109	134.41	138.93	108.67	101.7
Total Liabilities & Equity	113.79	113.83	140.39	151.39	119.98	107.79
Net Cash (Debt)	77.38	76.96	98.03	73.26	69.11	65.13
Net Cash Growth	-19.94%	-21.49%	33.81%	6.01%	6.11%	-4.43%
Net Cash Per Share	0.11	0.11	0.14	0.11	0.10	0.10
Filing Date Shares Outstanding	694.14	676.22	692.42	676.12	674.79	672.19
Total Common Shares Outstanding	694.14	676.22	692.42	676.12	674.79	670.89
Working Capital	80.9	80.77	98.78	110.22	77.77	70.01
Book Value Per Share	0.16	0.16	0.19	0.21	0.16	0.15
Tangible Book Value	109.07	109	126.79	138.93	108.67	101.7
Tangible Book Value Per Share	0.16	0.16	0.18	0.21	0.16	0.15
Buildings	-	17.43	17.43	17.43	17.43	17.43
Machinery	-	5.66	5.68	5.46	5.32	5.24

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.